OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 05, 2010
FDA Approves Flu Vaccines; Caraco Names COO; And More.
August 02, 2010
Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.
Industry can meet its responsibility to society by considering innovative pricing and partnerships.
Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
August 01, 2010
As emerging markets become increasingly important for the pharmaceutical majors, companies are re-evaluating their outsourcing strategies. This article is part of the 2010 Outsourcing Resources special issue.
Many pharmaceutical companies in the UK have adopted a direct-to-pharmacy distribution model, which enables companies to more tightly control their supply chains.
The health of the contract-services industry is improving but the market is signaling tougher competition ahead. This article is part of the 2010 Outsourcing Resources special issue.
Representatives of SOCMA and IPEC explain new quality agreement templates and their use for meeting regulatory expectations and securing the pharmaceutical supply chain.